When the liver is damaged by heavy alcohol use, doctors are looking beyond it to another part of the body: the gut. A new review of existing research suggests that therapies targeting the community of bacteria in our intestines—like taking specific probiotics or receiving a fecal microbiota transplant (FMT)—could potentially help. The idea is that these treatments might enhance liver function and reduce harmful inflammation in patients with alcohol-associated liver disease (ALD).
However, the findings from various studies are all over the map. Researchers haven't found a single, reliable bacterial signature in the gut that can diagnose this liver condition. Different studies have used different methods and often worked with small groups of people, leading to conflicting and inconsistent results. This makes it hard to know what really works.
While probiotics and FMT show some promise, another approach called bacteriophage therapy—using viruses to target specific gut bacteria—remains purely experimental for now. The review concludes that turning these gut-focused ideas into real medical treatments will require solving big technical and ethical challenges, and most of all, a lot more rigorous research. For now, it's a field of intriguing possibilities, not proven solutions.